HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma (Q40779159)

23 September 2017

HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma (English)

1 reference

23 September 2017

1 reference

1 reference

Brien TP

1

1 reference

23 September 2017

Odze RD

2

1 reference

23 September 2017

Sheehan CE

3

1 reference

23 September 2017

McKenna BJ

4

1 reference

23 September 2017

Ross JS

5

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

23 September 2017

1 reference

23 September 2017

31

1 reference

23 September 2017

35-39

1 reference

23 September 2017

1

1 reference

describes a project that uses

23 September 2017

fluorescence in situ hybridization

1 reference

The increasing frequency of adenocarcinoma of the esophagus

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

Continuing climb in rates of esophageal adenocarcinoma: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

Amplification and over-expression of theEGFR anderbB-2 genes in human esophageal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980195-1

7 January 2021

10.1016/S0046-8177(00)80195-1

Identifiers

DOI

1 reference

23 September 2017

1 reference